Previous close | 7.13 |
Open | 7.16 |
Bid | 7.30 x 100 |
Ask | 7.33 x 400 |
Day's range | 7.14 - 7.51 |
52-week range | 2.62 - 13.70 |
Volume | |
Avg. volume | 631,270 |
Market cap | 455.586M |
Beta (5Y monthly) | 2.28 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors who take an interest in Fulcrum Therapeutics, Inc. ( NASDAQ:FULC ) should definitely note that the CEO...
Fulcrum Therapeutics ( NASDAQ:FULC ) Full Year 2023 Results Key Financial Results Net loss: US$97.3m (loss narrowed by...
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript February 27, 2024 Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44. FULC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Fulcrum […]